The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

Authors

Salvatore Facciorusso
Stefania Spina
Alessandro Picelli
Alessio Baricich
Gerard E Francisco
Franco Molteni
Jörg Wissel
Andrea Santamato

Publication Date

4-9-2024

Journal

Toxins

Abstract

Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the management of spasticity. This paper presents a comprehensive bibliometric and visual analysis of research concerning BoNT-A treatment of spasticity to elucidate current trends and future directions in this research area. A search was conducted in the Web of Science database for articles focused on the use of BoNT-A in spasticity published between 2000 and 2022. We extracted various metrics, including counts of publications and contributions from different countries, institutions, authors, and journals. Analytical methods in CiteSpace were employed for the examination of co-citations, collaborations, and the co-occurrence of keywords. Our search yielded 1489 publications. Analysis revealed a consistent annual increase in research output. The United States, United Kingdom, and Italy were the leading contributors. The top institution in this research was Assistance Publique Hopitaux, Paris. The journal containing the highest number of relevant publications was Toxins. Key frequently occurring keywords were ‘stroke’, ‘cerebral palsy’, ‘adult spasticity’, and ‘upper extremity’. This study identified 12 clusters of keywords and 15 clusters of co-cited references, indicating the main focus areas and emerging themes in this field. This study comprehensively analyzed and summarized trends in BoNT-A research in the field of spasticity over the past 22 years.

Keywords

BoNT-A, spasticity, bibliometric analysis, research trends, neurological disorders

Comments

Supplementary Materials

PMID: 38668609